Advertisement


Flora E. van Leeuwen, PhD, on Hodgkin Lymphoma Treatment: Toxicities in Female Survivors

2018 Cancer Survivorship Symposium: Advancing Care and Research

Advertisement

Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute, discusses cardiovascular disease risk after treatment-induced primary ovarian insufficiency in female survivors of Hodgkin lymphoma (Abstract 114).



Related Videos

Survivorship

Paul B. Jacobsen, PhD, on The Impact of Survivorship Care Plans: Expert Perspective

Paul B. Jacobsen, PhD, of the National Cancer Institute, discusses his evaluation of whether survivorship care plans have a positive impact on health outcomes and health-care deliv...

Survivorship

Christopher J. Recklitis, PhD, MPH, on Mental Health in Cancer Survivors

Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, summarizes two key papers on mental health: suicide risk among survivors of head and neck cancer vs other types...

Supportive Care
Survivorship

Christopher J. Recklitis, PhD, MPH, on Sexual Aids and Supportive Care: Study Findings

Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, discusses a study investigating the availability of supportive care sexual aids and resources for cancer surviv...

Survivorship

Patricia A. Ganz, MD, on Progress in Cancer Survivorship Care

Patricia A. Ganz, MD, of the University of California, Los Angeles, and this year’s recipient of the Ellen Stovall Award for Advancement of Cancer Survivorship Care, discusses her ...

Survivorship

Carrie R. Howell, PhD, on Reducing Risks for Childhood Cancer Survivors: Trial Results

Carrie R. Howell, PhD, of St. Jude Children’s Research Hospital, discusses study findings on a web-based exercise intervention for adolescent survivors, who are at increased risk f...

Advertisement

Advertisement



Advertisement